Biogen (BIIB) Minority Interest (2009 - 2023)
Biogen (BIIB) posted quarterly Minority Interest of -$4.1 million for Q3 2023, up 52.87% year-over-year from -$2.7 million in Q3 2022, and up 35.94% quarter-over-quarter from -$6.4 million in Q2 2023.
Biogen (BIIB) Minority Interest (2009 - 2023) Analysis & Trends
Biogen's Minority Interest history runs 15 years deep, the most recent figure standing at -$4.1 million for Q3 2023.
- In Q3 2023, Minority Interest rose 52.87% year-over-year to -$4.1 million; the TTM figure through Sep 2023 stood at -$4.1 million (up 52.87% YoY), while the FY2022 annual figure was -$9.5 million, down 114.96% from the prior year.
- Minority Interest for Q3 2023 stood at -$4.1 million, up from -$6.4 million in the prior quarter.
- The five-year high for Minority Interest was $462.9 million in Q2 2021, with the low at -$21.6 million in Q1 2022.
- The 5-year median for Minority Interest is -$8.7 million (2022), against an average of $42.8 million.
- The sharpest annual moves came in 2020 and 2021: Minority Interest slumped 375.61% in 2020, then soared 3327.14% in 2021.
- Biogen's Minority Interest stood at -$4.1 million in 2019, then sank by 246.34% to -$14.2 million in 2020, then soared by 547.18% to $63.5 million in 2021, then slumped by 114.96% to -$9.5 million in 2022, then jumped by 56.84% to -$4.1 million in 2023.
- Business Quant data shows BIIB's Minority Interest at -$4.1 million in Q3 2023, -$6.4 million in Q2 2023, and -$9.6 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -4.10 Mn |
| Jun 30, 2023 | -6.40 Mn |
| Mar 31, 2023 | -9.60 Mn |
| Dec 31, 2022 | -9.50 Mn |
| Sep 30, 2022 | -8.70 Mn |
| Jun 30, 2022 | -9.10 Mn |
| Mar 31, 2022 | -21.60 Mn |
| Dec 31, 2021 | 63.50 Mn |
| Sep 30, 2021 | 451.80 Mn |
| Jun 30, 2021 | 462.90 Mn |
| Mar 31, 2021 | -19.00 Mn |
| Dec 31, 2020 | -14.20 Mn |
| Sep 30, 2020 | -14.00 Mn |
| Jun 30, 2020 | -19.50 Mn |
| Mar 31, 2020 | -10.00 Mn |
| Dec 31, 2019 | -4.10 Mn |
| Sep 30, 2019 | -4.10 Mn |
| Jun 30, 2019 | -4.10 Mn |
| Mar 31, 2019 | -7.90 Mn |
| Dec 31, 2018 | -8.00 Mn |